hit counter
USA Life Sciences Database
Biotechgate Biotechgate Global Database › Global Trial › Global Log-in ›
Life Sciences Database
Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry

Results 261 - 280 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13 14  15  16  17  18  19  20  21  22  23  24  25 »

Daré Bioscience, Inc. Announces Licensing and Global Rights to Novel Phase III Product Candidate for the Treatment of Bacterial Vaginosis

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  Daré Bioscience, Inc.

Kiniksa Provides Update on U.S. FDA Review of Investigational New Drug Application for Mavrilimumab in Giant Cell Arteritis

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  Kiniksa Pharmaceuticals Corp.

Rexahn Pharmaceuticals Streamlines Operations and Provides Update on Pipeline

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  Rexahn Pharmaceuticals, Inc.

VBI Vaccines Enters into License and Collaboration Agreement with Brii Biosciences for up to $129 Million plus Royalties to Develop a Functional Cure for Hepatitis B

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  VBI Vaccines Inc.

Chembio’s French Partner AAZ-LMB Wins Prix Galien International for Best Medical Technology with autotest VIH®

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  Chembio Diagnostics, Inc.

BioSig Technologies To Commence First–in-Human Studies at Mayo Clinic

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  BioSig Technologies, Inc.

Avinger Announces Commercial Launch in Australia

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  Avinger, Inc.

Rhythm Pharmaceuticals to Host Key Opinion Leader Symposium on MC4R Pathway and Patient Experience with Rare Genetic Disorders of Obesity, Including Bardet-Biedl Syndrome

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  Rhythm Pharmaceuticals Inc.

Ovid Therapeutics Announces Plans to Move into a Phase 3 Trial in Pediatric Patients Based on End-of-Phase 2 Meeting for OV101 in Angelman Syndrome

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  Ovid Therapeutics Inc.

Nuvectra Completes 3,000 U.S. Algovita® SCS Implantations

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  Nuvectra Corporation

Immunomedics Provides Clinical Updates on Breast Cancer Programs With Sacituzumab Govitecan

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  Immunomedics, Inc.

Organovo Appoints New Board Member

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  Organovo Holdings, Inc.

First Choice Healthcare Solutions Governance Appointments

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  Vets First Choice

Myriad Validates Polygenic Score to Predict Breast Cancer Risk in Women of Hispanic Ancestry Who Test Negative for Hereditary Cancer Mutations

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  Myriad Genetics, Inc.

Ultragenyx and Kyowa Kirin Announce Health Canada Approval of Crysvita™ (burosumab injection) for the Treatment of X–linked Hypophosphatemia (XLH) in Adults and Children

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  Ultragenyx Pharmaceutical, Inc.

Marrone Bio Innovations Launches TerraConnect™ New Biological Seed and Soil Platform

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  Marrone Bio Innovations, Inc.

Matinas BioPharma Assembles World Class Scientific Advisory Board to Guide Clinical Development Strategy of Potential Best-in-Class Prescription-Only Omega-3, MAT9001

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  Matinas BioPharma Holdings Inc.

Adamis Pharmaceuticals Provides Update on the U.S. Launch of SYMJEPI

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  Adamis Pharmaceuticals Corporation

Novartis investigational BYL719 (alpelisib) plus fulvestrant consistently improved PFS in patients with PIK3CA mutated HR+/HER2- advanced breast cancer in new SOLAR-1 analyses

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
Related companies:  Novan, Inc.

VALNEVA and HOOKIPA Sign a Collaboration and Manufacturing Agreement

Read more ››
By: Nasdaq / GlobenewsWire - 06 Dec 2018
«  1  2  3  4  5  6  7  8  9  10  11  12  13 14  15  16  17  18  19  20  21  22  23  24  25 »

Looking for companies outside of the United States?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

  • December 2018
    • London: The Pharma Business Development Course - An Overview Course
    • London: Genesis 2018
  • January 2019
    • San Francisco: Biotech Showcase
See Events »
Add an Event »

Latest company news

Improved Accuracy and Speed for Disease Research, Two Genomic Companies Integrate Kits and Software to Enable Deep Exploration of Epigenetic Data
12 Dec 2018 (Nasdaq / GlobenewsWire)

VBI Vaccines Announces Proposed Public Offering of Common Shares
12 Dec 2018 (Nasdaq / GlobenewsWire)

AGTC Announces Topline Interim Six-Month Data from Phase 1/2 X-Linked Retinoschisis Clinical Study; Termination of Biogen Collaboration
12 Dec 2018 (Nasdaq / GlobenewsWire)

Biotechgate database

About Biotechgate
The USA Life Sciences Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com